Inside the 2026 DCAT Member Company Announcement Forum

Live From Show Updates

At DCAT Week, Axplora Highlights Major HPAPI Expansion Strategy

CCO Arul Ramadurai discusses Axplora’s strategy for high-potency growth.

SPONSOR

Streamline HME Projects with Early Partner Engagement

Hot-melt extrusion (HME) is an advantageous method for enhancing the solubility and bioavailability of poorly soluble active pharmaceutical ingredients (APIs) — if the formulation is robust and scalable. Partnering early on with an experienced CDMO can help accelerate the development of optimal, scalable, and patient-centric HME products.

Live From Show Updates

Lonza Launches Media Development Lab in Singapore for Cell Culture Media Optimization

Offering aims to improve performance, reduce risk, and help ensure smooth scale-up into manufacturing.

Live From Show Updates

Apollo to Acquire Minority Stake in Syntegon from CVC

Apollo to support new momentum and local expertise for the North American market.

SPONSOR

Let’s take your OSD project to the next level!

Wow, cheers to a successful 2026 DCAT! We’re excited to continue the conversations and explore how Ropack Pharma Solutions can support your next project. Let’s stay connected!

Live From Show Updates

Piramal Pharma Solutions Installs Korsch X3 Tablet Press at Morpeth Facility

Press equipped with full Band 5 containment for manufacture of highly potent drug products at clinical and commercial scales.

Breaking News

Rentschler Biopharma Advances Milford Site Expansion

Following the company’s largest expansion, the newest production line at its Milford, MA site is fully operational.

SPONSOR

Meet the makers of more tomorrows at DCAT Week

Discover how Kindeva helps bring life-changing therapies to patients faster. Meet us March 23–26.

SPONSOR

Bring us your batch. We’ll deliver.

Complex molecule? Difficult process? We’re your people. We’ve got a decades-long history of problem solving and fear-no-challenge culture.

SPONSOR

Ahead of DCAT Week, IPP Offers Unique Capital-Light Route into World-Class API Manufacturing Capacity

International Process Plants (IPP) announces a direct path into commercial volume small molecule API manufacturing for pharmaceutical & CDMO companies at its Grimsby, UK platform—without the capital burden of acquisition or greenfield buildout.